Newbury Pharmaceuticals AB (publ) (STO:NEWBRY)
Sweden · Delayed Price · Currency is SEK 2.720
-0.160 (-5.56%)
Aug 14, 2026, 5:29 PM CET
STO:NEWBRY Market Cap
STO:NEWBRY has a market cap or net worth of 82.68 million as of August 14, 2026. Its market cap has increased by 5.02% in one year.
Market Cap
82.68M
Enterprise Value
68.00M
Revenue
35.02M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.72
ChartMarket Cap Chart
Since February 4, 2022, STO:NEWBRY's market cap has decreased from 245.97M to 82.68M, a decrease of -66.38%. That is a compound annual growth rate of -21.41%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 82.68M | 136.52% |
| Dec 30, 2025 | 34.96M | -59.06% |
| Dec 30, 2024 | 85.39M | 42.48% |
| Dec 29, 2023 | 59.93M | -56.08% |
| Dec 30, 2022 | 136.45M | -44.52% |
| Feb 4, 2022 | 245.97M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nanexa AB | 854.64M |
| Dicot Pharma AB | 709.69M |
| EQL Pharma AB | 699.85M |
| Cinclus Pharma Holding AB | 562.18M |
| Orexo AB | 546.17M |
| Moberg Pharma AB | 535.81M |
| Enzymatica AB | 474.55M |
| Klaria Pharma Holding AB (publ.) | 225.81M |